Delivery Order SPE2DB25D7067-SPE2DB25FSVTU
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of MENQUADFI vial 0.5ML, a meningococcal vaccine product. The contract is valued at $2,179.32 with a firm fixed price structure and an ultimate completion date of July 30, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $2,905.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Menquadfi vial 0.5mL, a meningococcal vaccine. The contract, which is not set aside and was competitively awarded, calls for ultimate completion by August 14, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine medical procurement action supporting federal...
- On July 29, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,452.88 to AmerisourceBergen Drug Corp for the supply of Menquadfi vial 0.5ML, a meningococcal vaccine product. The contract is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. The delivery order is a...
- The Defense Logistics Agency awarded a $2,823.27 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of MENQUADFI vial 0.5ML, a meningococcal vaccine product. The delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by July 29, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $15,255.24 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Menquadfi vial 0.5ML, a meningococcal vaccine product. The delivery order, which represents a child contract action under a larger vehicle, is scheduled for completion by August 19, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,990.84 by the Defense Logistics Agency's Medical Supply Chain on August 20, 2025, with an ultimate completion date of August 21, 2025. The contract, designated as a firm fixed-price delivery order without set-aside, covers the supply of Menquadfi vials (0.5mL), a meningococcal vaccine product. This award is issued as a child contract under...
- The Defense Logistics Agency awarded a $1,452.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Menquadfi vial 0.5ml, a meningococcal vaccine product. The contract was competitively awarded with no set-aside designation and is scheduled for completion by August 12, 2025. AmerisourceBergen will perform work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $2,179.32 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5mL) to support federal medical procurement needs. This non-competitive delivery order, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a firm fixed-price transaction under a larger contract vehicle. The work will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $21,401.45 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5ML) on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $7,264.50 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5mL) with a firm fixed price arrangement. The award was made on August 19, 2025, with an ultimate completion date of August 20, 2025, and represents a non-set-aside, competitively awarded procurement. Performance will be executed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB25FSVTUDelivery Order
The Defense Logistics Agency awarded a $7,264.50 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Menquadfi vial 0.5ml, a meningococcal vaccine product. This firm fixed-price delivery order, with an ultimate completion date of September 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively made with no set-aside designation, and performance will take place at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, holds a significant $999,999,999 IDC with DLA Troop Support Medical through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies, including vaccines, specialty medications, and medical devices, to support military healthcare programs globally. The current delivery order for Menquadfi vaccine exemplifies the type of critical medical commodities delivered through this strategic contract framework to support Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 9/3/25 |